← Evidence map

ArticleOphthalmology and therapy2019

Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens with Pre-Surgical "Pulse" Dose.

Steven M SilversteinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31552543